Merus Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/26/2026
- S&P 500, Nasdaq set for sharp weekly fall as chips stocks slide
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
- Needham Starts NeoVolta (NEOV) at Buy
- TD Cowen: 'Sober View Suggests Structural Alcohol Risks Are Overblown'
- Two major earthquakes strike Venezuela, killing at least 32 and injuring hundreds
- Hertz cuts guidance, announces notes and stock offerings, shares sink
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
Merus B.V. (MRUS) IPO Opens Modestly Lower
May 19, 2016 10:28 AM EDTToday's IPO for Merus B.V. (Nasdaq: MRUS) opened for trading at $9.75 after pricing 5,500,000 common shares at an initial public offering price of $10.00 per share, below the expected $14-$16 range. The size of the offering was increased from 4,333,333.
Citigroup Global Markets Inc. and Jefferies LLC are acting as joint book-running managers for the offering, Guggenheim Securities, LLC is acting as lead manager for the offering and Wedbush PacGrow is acting as co-manager for the offering.
Merus B.V. is a clinical-stage immuno-oncology company... More
